Virtus Investment Advisers’s ResMed RMD Stock Holding History

Virtus Investment Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.67M	Sell	7,427 -8	-0.1%	-$1.99K	0.46%	90
2025 Q4	$1.79M	Buy	7,435 +734	+11%	+$188K	0.49%	84
2025 Q3	$1.83M	Buy	6,701 +825	+14%	+$225K	0.53%	78
2025 Q2	$1.52M	Buy	5,876 +191	+3%	+$45.6K	0.51%	67
2025 Q1	$1.27M	Buy	+5,685	New	+$1.33M	0.35%	84
2023 Q1	–	Sell	-339	Closed	-$70.6K	–	334
2022 Q4	$70.6K	Hold	339	–	–	0.05%	294
2022 Q3	$74K	Buy	+339	New	+$77.2K	0.03%	321
2018 Q1	–	Sell	-2,740	Closed	-$232K	–	356
2017 Q4	$232K	Sell	2,740 -249	-8%	-$20.6K	0.03%	384
2017 Q3	$231K	Buy	+2,989	New	+$229K	0.02%	395

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtus Investment Advisers's RMD Position: Q1 2026 in Review

Virtus Investment Advisers reduced its ResMed (RMD) stake by 0.11% in Q1 2026, selling an estimated $1.99K and leaving 7,427 shares worth $1.67M. The position accounts for 0.46% of the portfolio, ranked #90.

Virtus Investment Advisers first reported a position in RMD in Q3 2017 and has held it in 9 quarters since. The position peaked at $1.83M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Virtus Investment Advisers held 7,427 shares of ResMed worth $1.67M as of Q1 2026.
Virtus Investment Advisers sold 8 ResMed shares in Q1 2026, an estimated $1.99K.
ResMed made up 0.46% of Virtus Investment Advisers's portfolio in Q1 2026, its #90 holding.
Virtus Investment Advisers first reported a position in ResMed in Q3 2017 and has held it in 9 quarters since.
Virtus Investment Advisers's ResMed position peaked at $1.83M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.